Immatics N.V. Ordinary Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for IMTX, updated each market day.
IMTX AI Sentiment
AI sees no strong directional signal for Immatics N.V. Ordinary Shares stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Immatics N.V. Ordinary Shares
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Exchange
Market Cap
$1,429,469,500
Cap Tier
Employees
407
Listed Since
July 2, 2020
Website
IMTX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
IMTX Volatility
Immatics N.V. Ordinary Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
